Test Price
2,800 AED✅ Home Collection Available
ATP10A Gene Sequencing (NGS) – Comprehensive Genetic Susceptibility Assessment for Autism, Intellectual Disability & Angelman Syndrome
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑certified, DHA‑licensed processing. Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM. Clinical Guidance: Telephonic post‑test result interpretation by a Consultant Medical Genetics specialist. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Corporate Laboratory: DNA Labs UAE (DHA Facility License No. 1143).
Test Overview & Methodology
The ATP10A gene encodes a phospholipid-transporting ATPase (Type IV P-type ATPase) involved in the translocation of phospholipids across cellular membranes. Pathogenic variants in this gene are strongly linked to neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability, and Angelman syndrome. This comprehensive Next-Generation Sequencing (NGS) test screens the entire coding region and exon-intron boundaries for single-nucleotide variants (SNVs) and small insertions or deletions (indels) to provide a definitive molecular diagnosis.
Methodological Comparison
| Feature | Our Test (NGS) | Conventional Single‑Gene Test |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina platform, high coverage) | Sanger sequencing – limited to known hotspots |
| Turnaround Time | 21–28 Days (ISO‑accelerated) | 4–6 Weeks |
| Coverage | Full gene ±10 bp intron–exon boundaries | Selected exons only |
| Clinical Utility | Comprehensive detection (SNVs, indels, copy‑number alterations) | May miss novel or rare variants |
Physician Insight & Safety Protocols
“ATP10A sequencing provides critical insights into the genetic etiology of neurodevelopmental delay. However, results must be interpreted within the full context of the patient’s clinical presentation, family history, and multidisciplinary evaluation. A negative result does not rule out other genetic or environmental causes.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403)
Advisory & Medication Safety
⚠ Clinical Advisory
Do not discontinue any prescribed medication without consulting your doctor. Genetic findings are not a substitute for ongoing clinical care. If you experience new or worsening symptoms, seek immediate medical attention.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to obtain informed consent from the patient or legal guardian (mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Exclusion: Active coagulopathy or severe infection contraindicating venipuncture; saliva-based collection kits remain an option.
- 🚨 Red Flag: Sudden loss or regression of developmental milestones – seek immediate emergency care regardless of pending test status.
- 🚨 Red Flag: First‑time seizure, loss of consciousness, or acute behavioural change.
Patient FAQ & Clinical Guidance
1. What is the clinical significance of ATP10A gene variants?
ATP10A variants are strongly linked to autism spectrum disorder, intellectual disability, and Angelman‑like phenotypes. This NGS test provides a definitive molecular diagnosis with 99.9% analytical sensitivity, guiding early intervention and family planning.
2. How is the test performed and what is the process?
A simple blood draw or saliva sample is collected at your home via our VIP mobile phlebotomy service. The sample is transported under a temperature-controlled cold chain to our ISO‑certified laboratory. Results are delivered in 21–28 days with a detailed clinical report and a telephonic consultation with our genetics team.
3. Is this test covered by UAE health insurance?
We provide direct billing verification via WhatsApp at +971 54 548 8731. Most UAE insurers cover neurodevelopmental genetic testing when medically indicated, including autism spectrum disorder and Angelman syndrome assessments.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
All genetic data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and informed consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genomic data is encrypted, anonymized, and never shared without explicit written consent.
Clinical & Logistical Metadata
| Test Name | ATP10A Gene Sequencing (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 21–28 Days |
| Sample Type / Matrix | Peripheral Whole Blood, Saliva / OGM-1 Collection Kit |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina Platform |
| ICD-10-CM Code | Z13.71, F84.0, Q93.5 |
| LOINC Code | 94835-8 |
| DHA Facility License & Lab Address | DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA Facility License No. 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians